2Ragmond E,Faiver S,Woynarowsk I,et al.Oxaliplatin:mechanism of mechanism of action and antineoplastic activity.Seninars in Oncology,1998,25(5):4.
3Ragmond E,Chaney SG,Tamma A,et al.Oxaliplatin:a review of preclinical and clinical studies.Annals Oncol,1998,9:1053.
4De Gramont A,Figer A,Seymonr M,et al.Leucovorin and fluorouracil with or without oxaliplatin as first-linetreatment in advanced colorectal cancer.J Clinical Oncol,2000,18:2938.
5Therasse P,Eisenhauer E.A, Verweij J. RECIST revisited: a review of validation studies on tumour assessment[ J]. Eu- ro J of Cancer,2006,42(8) :11031.
6Subbaramaiah K, Lakim D, Weksler B, et al. Inhibition of cyclooxygenase :a novel approach to cancer prevention [ J 1. Proe Soc Exp Biol Med,1997,216(2) :201.
7Gaffney DK, Holden J, Davis M, et al. Elevated cyclooxyge- nase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy[ J]. lnt J Radiat Oncol Biol Phys ,2006 ,49 ( 5 ) : 1213.
